
Keywords: APS; antiphospholipid syndrome; aPTT; activated partial thromboplastin time; BM; balloon maceration; CVC; central venous catheter; CVST; cerebral venous sinus thrombosis; DVST; Dural venous sinus thrombosis; ET; endovascular treatment; GC; guiding cathete